Delivery Order SPE2DE24DA010-SPE2D625F8V89

Award Date 3/24/25
Potential Completion Date 3/27/25
Potential Value $1.3K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
This federal contract award, valued at $11,750.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company, through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of March 3, 2025. The award does not have a set-aside designation, indicating full and open competition. The contract provides for the delivery of...
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company that specializes in medical devices, diagnostics, and pharmaceuticals. The award is a delivery order contract with a fixed price and economic price adjustment mechanism. The contract has no set-aside designation, indicating full and open competition. The contract requires Abbott Laboratories Inc., through its Abbott Vascular Inc. division,...
This federal contract award, valued at $10,124, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. and its Abbott Vascular Inc. division. The contract is a Delivery Order for the provision of advanced cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of...
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a firm fixed-price delivery order with economic price adjustment, with an ultimate completion date of June 18, 2024. The award provides for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants....
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order without any set-aside designations, indicating full and open competition. The contract covers the delivery of a range of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. These products...
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order for fixed-price cardiovascular medical devices with economic price adjustment, with a completion date of March 18, 2025. The award was made under an Indefinite Delivery Contract (IDC), likely an existing Blanket Purchase Agreement (BPA) between Abbott Laboratories and the Department of...
This federal contract award, valued at $28,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a Delivery Order for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. This contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc....
This federal contract award, valued at $30,281.95, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a firm fixed-price delivery order for the delivery of cardiovascular medical devices and related services, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract does not have a set-aside designation, indicating full and open...
This is a federal contract award to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, by the Defense Logistics Agency (DLA) and Department of Veterans Affairs (VA). The $21,147.00 fixed-price delivery order contract, which has no set-aside designation, is for the provision of cardiovascular medical devices and related services to support federal healthcare systems. Abbott Laboratories, through its Abbott Vascular Inc. division, has a strong track record of...
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F8V89
    Delivery Order

This federal contract award, valued at $1,262.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a multinational pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract is a fixed-price delivery order with economic price adjustment, with a period of performance ending on March 27, 2025.

Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a key supplier of advanced medical technologies to federal healthcare systems, including the Department of Veterans Affairs (VA) and Defense Health Agency. The company provides a comprehensive range of cardiovascular medical devices, such as stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. This contract award is part of a larger portfolio of federal contract awards and Indefinite Delivery Vehicles (IDVs) that Abbott Laboratories Inc. has secured, demonstrating its strategic importance to federal healthcare systems. No set-aside designation was used for this contract award, indicating full and open competition.

Generated 7/1/25, 2:32 PM